What records are connected here?
- Evidence lanes
- 1
- Source years
- 7
- Drugs@FDA applications
- 0
These are counts in PeptideScanner’s selected public collection, not measures of research quality, medical relevance, safety, or effectiveness.
Not FDA-approved3Evidence: Limited human dataHormones
Also called Growth hormone-releasing peptide 61
GHRP-6 (growth hormone-releasing peptide 6) is a synthetic six-amino-acid peptide that FDA’s substance registry also records as hexapeptide-2.1 FDA has placed GHRP-6 in category 2 of its compounding lists, for substances that may present significant safety risks, citing possible immune reactions and possible effects on cortisol and blood sugar.3 No FDA approval is reported in the sources reviewed here, and GHRP-6 is not among the six peptides in HHS’s October 2026 draft enforcement-discretion policy.3,5
| What it is | A synthetic hexapeptide amide (His-D-Trp-Ala-Trp-D-Phe-Lys-NH2), also recorded as hexapeptide-2 and SK&F-110679, according to FDA’s substance registry.1 |
|---|---|
| FDA status | No FDA approval is reported in the sources reviewed here. Since September 29, 2023, FDA has listed GHRP-6 in category 2 under its interim policy for outsourcing facilities, for substances that may present significant safety risks.3 |
| Human evidence | Small studies of how the body handles it, such as a 2013 study in nine healthy men. FDA reports only limited safety information.2,3 |
| Evidence strength | Limited human data. The only cited human studies are small, short, uncontrolled, or incompletely reported, such as case series, pilot studies, or trials published only as a conference abstract whose methods and results cannot be checked. How this label is assigned |
GHRP-6 is a synthetic peptide of six amino acids, two of them in the unnatural D form, ending in an amide. FDA’s substance registry records it as hexapeptide-2, growth hormone-releasing peptide 6 and SK&F-110679.1
Its registered name, growth hormone-releasing peptide 6, describes its intended action of prompting the release of growth hormone. The authors of a 2013 study describe it as a growth hormone secretagogue.1,2
FDA states that the available data raise concerns about possible effects on cortisol and a rise in blood sugar from reduced insulin sensitivity.3
A 2013 study gave GHRP-6 to nine healthy men to measure how it is distributed and cleared. It reported a distribution half-life of about eight minutes and an elimination half-life of about two and a half hours.2
FDA reports that it has identified only limited safety-related information on GHRP-6. The sources reviewed here do not include trials of whether it is effective for any use.2,3
Evidence-strength label: Limited human data. How this label is assigned
None of the sources reviewed here reports an approval of GHRP-6 by FDA.1,3
FDA’s compounding safety-risk page, current as of April 22, 2026, lists GHRP-6 in category 2 under the interim policy for outsourcing facilities (section 503B) since September 29, 2023, citing possible immune reactions from aggregation and impurities.3
HHS’s October 30, 2026 draft enforcement-discretion policy lists six peptides in its Appendix A: BPC-157, Epitalon, KPV, MOTS-c, Semax and TB-500. GHRP-6 is not among them.4,5
Whether it is effective for any condition, which none of the sources reviewed here evaluates.2,3
How safe it is: FDA states that it has only limited safety-related information.3
PeptideScanner reports what the cited sources say. It is not medical advice and does not recommend using, buying or dosing any substance. Read the full disclaimer.
Go deeper
Everything PeptideScanner has collected for GHRP-6: reviews, official-source readings, registry and literature records, and every change to this profile.
What the trial and literature lists cover. The trials and papers listed for GHRP-6 are a bounded selection, not every registration or paper about GHRP-6. For the years before GHRP-6 was added, PeptideScanner took at most 25 ClinicalTrials.gov registrations that list GHRP-6 as an intervention: trials with posted results first, then later-phase trials, then the most recently updated. It also took at most 25 PubMed papers that name GHRP-6 in the title: randomized controlled trials, clinical trials, meta-analyses, systematic reviews and reviews first, then the most recent. Records that also named another tracked peptide, or that failed the publication checks, were left out. A daily check adds newly updated registrations and newly indexed papers that pass the same checks. How records are selected.
Evidence summary
No FDA approval reported; on FDA’s compounding safety-risk list (category 2). Human data are limited to small studies such as a pharmacokinetic study in nine healthy men. No FDA approval is reported in the cited sources, and GHRP-6 is not among the six peptides in HHS’s October 2026 draft enforcement-discretion policy.↗↗↗
Status sources checked through November 14, 2026. See status sources and coverage →
Explore this profile’s cited source records →
An editorial human-evidence summary has not yet been published.
Living status brief
No FDA approval reported; on FDA’s compounding safety-risk list (category 2). Human data are limited to small studies such as a pharmacokinetic study in nine healthy men. No FDA approval is reported in the cited sources, and GHRP-6 is not among the six peptides in HHS’s October 2026 draft enforcement-discretion policy.↗↗↗
The cited status sources were checked through November 14, 2026. This answer changes only through the profile’s visible version and correction history.
These are counts in PeptideScanner’s selected public collection, not measures of research quality, medical relevance, safety, or effectiveness.
Literature metadata · source date November 1, 2026
GHRP-6 in heifer and cow adenohypophisial cells separated by elutriation.↗Added to PeptideScanner November 16, 2026Literature metadata · added November 16, 2026
GHRP-6 in heifer and cow adenohypophisial cells separated by elutriation.↗Source date November 1, 2026Literature metadata · added November 16, 2026
Growth hormone (GH) peaks versus areas under the curve in the diagnosis of adult GH deficiency: analysis of the variables provided by the GHRH + GHRP-6 test.↗Source date October 19, 2026Literature metadata · added November 16, 2026
Impairment of GH responsiveness to GH-releasing hexapeptide (GHRP-6) in Prader-Willi syndrome.↗Source date October 12, 2026PeptideScanner currently has no selected clinical trial records, regulatory records, and safety records connected to this profile. That is a collection gap, not evidence that no such records exist.
PeptideScanner does not infer an answer where the cited records do not provide one. Open the source-linked records below to inspect their scope and limits.
Evidence Map v1
This map describes PeptideScanner’s selected, source-linked collection. It is not an evidence grade and does not establish research quality, safety, effectiveness, or medical relevance.
0 of 0 selected trial records include at least one phase value; 0 of 0 include a status value in the retained structured contract.
25 of 25 selected PubMed records include attributed title, venue, publication date, and publication-type fields.
Application counts reflect exact reviewed ingredient connections; Federal Register counts reflect exact reviewed peptide-name matches; DailyMed counts reflect listed SPL versions with retained ZIP receipts. “Published” describes this page’s indexing surface, not the state of scientific evidence.
Research hub
PeptideScanner change dates and cited source dates stay separate. These entries report collection or version activity, not a ranking of importance.
PubMed lists PMID 10218787 in Neuroscience as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1999-03 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-6. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PubMed lists PMID 10362518 in Biochemical and biophysical research communications as Journal Article, with publication-date metadata of 1999-06-07 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-6. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
PubMed lists PMID 10494658 in Journal of physiology and biochemistry as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1999-03 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-6. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.
25 with attributed title, venue, publication-date, and type metadata.
Selected records span November 23, 2016 to November 1, 2026. These dates come from selected source records and PubMed metadata, not a complete or continuous timeline of research, safety, approval, or effectiveness.
These links are based only on overlapping years and evidence lanes in PeptideScanner’s selected records. They do not imply that the peptides are medically or scientifically similar.
Literature metadata
PubMed lists PMID 10494658 in Journal of physiology and biochemistry as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 1999-03 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-6. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 15638293 in Pituitary as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2004 (year precision). PeptideScanner associated the retained record with the identity slug ghrp-6. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 11407654 in Journal of endocrinological investigation as Journal Article, with publication-date metadata of 2001-05 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-6. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 25194405 in Iranian journal of kidney diseases as Journal Article, with publication-date metadata of 2014-09 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-6. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 17622118 in AAPS PharmSciTech as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2007-06-08 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-6. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 42258095 in Pharmacological reports : PR as Journal Article, with publication-date metadata of 2026-06-08 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-6. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 22154075 in Journal of pharmaceutical and biomedical analysis as Journal Article, Validation Study, with publication-date metadata of 2011-11-15 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-6. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 12606621 in The Journal of pharmacology and experimental therapeutics as Comparative Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2003-02-11 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-6. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 22211090 in International journal of medical sciences as Journal Article, Research Support, N.I.H., Intramural, with publication-date metadata of 2011-11-18 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-6. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 22211109 in International journal of biological sciences as Journal Article, Research Support, N.I.H., Intramural, with publication-date metadata of 2011-11-26 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-6. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 32454141 in Physiology & behavior as Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2020-05-23 (day precision). PeptideScanner associated the retained record with the identity slug ghrp-6. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Literature metadata
PubMed lists PMID 12201831 in Clinical endocrinology as Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't, with publication-date metadata of 2002-09 (month precision). PeptideScanner associated the retained record with the identity slug ghrp-6. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗
Citations
Numbered markers in the text point here. Each link opens the original public record.
FDA Global Substance Registration System · Official source · Source checked November 15, 2026
European Journal of Pharmaceutical Sciences · Official source · Source checked November 15, 2026
U.S. Food and Drug Administration · Official source · Source checked November 14, 2026
Federal Register · U.S. Department of Health and Human Services · Official source · Source checked November 14, 2026
U.S. Department of Health and Human Services · Official source · Source checked November 14, 2026